Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Treasury Shares (2021 - 2025)

Historic Treasury Shares for Roivant Sciences (ROIV) over the last 5 years, with Q1 2025 value amounting to $348527.0.

  • Roivant Sciences' Treasury Shares fell 9693.08% to $348527.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $348527.0, marking a year-over-year decrease of 9693.08%. This contributed to the annual value of $348527.0 for FY2025, which is 9693.08% down from last year.
  • As of Q1 2025, Roivant Sciences' Treasury Shares stood at $348527.0, which was down 9693.08% from $51.5 million recorded in Q4 2024.
  • Roivant Sciences' 5-year Treasury Shares high stood at $52.0 million for Q3 2024, and its period low was $348527.0 during Q1 2025.
  • In the last 5 years, Roivant Sciences' Treasury Shares had a median value of $21.5 million in 2021 and averaged $23.3 million.
  • In the last 5 years, Roivant Sciences' Treasury Shares surged by 18247.68% in 2024 and then tumbled by 9693.08% in 2025.
  • Roivant Sciences' Treasury Shares (Quarter) stood at $22.6 million in 2021, then decreased by 1.92% to $22.2 million in 2022, then dropped by 17.73% to $18.2 million in 2023, then skyrocketed by 182.48% to $51.5 million in 2024, then plummeted by 99.32% to $348527.0 in 2025.
  • Its Treasury Shares stands at $348527.0 for Q1 2025, versus $51.5 million for Q4 2024 and $52.0 million for Q3 2024.